Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Nuclear Medicine Market Size, Share and Forecast 2015 to 2022

The Nuclear Medicine Market Research Report provides forecast and estimates for each application in terms of Market Size, Share, Trend & Growths.
sumona gupta | 05.12.2016
©
The Nuclear Medicine Market Research Report published by DecisionDatabases.com provides industry analysis and evaluation of the current and prospective market size, share, trend, growth and forecast during the study period (2015-2022).

The global nuclear medicine/radiopharmaceuticals market research report provides detailed information about the industry based on the revenue (USD MN) for the forecast period. The research study is a descriptive analysis of this market emphasizing the market drivers and restraints that govern the overall market growth. The trends and future prospects for the market are also included in the report which gives an intellectual understanding of the nuclear medicine/radiopharmaceuticals industry.

Download Free Sample Copy Of this Report :
http://www.decisiondatabases.com/contact/download-sample-8182

The report offers a value chain analysis that gives a comprehensive outlook of the nuclear medicine/radiopharmaceuticals market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.

A glimpse of the major drivers and restraints affecting the vein illumination devices market is mentioned below.

A. Drivers :

- Increase in the number of new cancer cases
- Rising adoption of SPECT and PET Scans
- Increase in preference for radiation therapy for cancer treatment
- Developments in imaging technologies using radiopharmaceuticals

B. Restraints :
- Stringent regulatory policies
- Competition from conventional alternative diagnostic procedures

The nuclear medicine/radiopharmaceuticals market has been segmented based on cardiology, neurology, oncology, thyroid, bone metastasis, and endocrine tumors. The report provides forecast and estimates for each application in terms of market size during the study period. Each application has been further analyzed based on regional and country levels.

C. Major player assessed in the report are :
- Bayer Healthcare AG
- Cardinal Health, Inc.
- Eczacibasi-Monrol Nuclear Products
- GE Healthcare
- IBA Molecular Imaging
- Jubilant Pharma
- Mallinckrodt plc
- More

Geographically, this market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America and the Middle East And Africa. The study details country-level aspects based on each segment and gives estimates in terms of market size.

View More About this Report : http://www.decisiondatabases.com/ip/8182-nuclear-medicine-radiopharmaceuticals-market-report

D. SEGMENTATIONS IN THE REPORT :

1. Nuclear Medicine/Radiopharmaceuticals Market Analysis by Product Type :

- Diagnostics
- SPECT Isotopes
- PET Isotopes
- Therapeutics
- Alpha Emitters
- Beta Emmiters
- Brachytherapy

About DecisionDatabases.com


DecisionDatabases.com is one stop shop for your Market research requirements like market reports, company profiles and industry databases. Our team consists of expert Business Analysts who have been trained to map your research requirement to the correct research resource.

Contact:
DecisionDatabases.com
Phone:
+91 99 28 237112
Email: sales@decisiondatabases.com
Web: www.decisiondatabases.com